一个基于微观分析的紧差动态装置 (cDDM):一种方法工具,用于在输血依赖β-血病患者中早期检测高凝血状态
Touchwin Petiwathayakorn1, Narisara Paradee1, Sasinee Hantrakool2
1Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
ACS applied bio materials
|June 26, 2024
概括
输血依赖性沙拉西米亚 (TDT) 患者表现出高凝血状态. 一个新的紧的微分动态显微镜装置准确地测量了血粘度,有助于在TDT中早期检测高凝血能力和预防血栓栓塞事件 (TEE).
科学领域:
- 血液学 血液学 血液学
- 生物物理学的生物物理.
- 医学诊断 医学诊断 医学诊断
背景情况:
- 输血依赖性血症 (TDT) 与高凝血状态有关,增加了血栓栓塞事件 (TEE) 的风险.
- 传统上,评估高凝性需要大量的样本,并且对于常规监测来说是不切实际的.
- 血粘度和风湿学参数是TDT中高凝血性的潜在指标.
研究的目的:
- 开发和验证一个紧的微分动态显微镜 (cDDM) 装置,用于在TDT患者中快速测量血粘度.
- 评估cDDM测量的血粘度与已确定的高凝度标志物之间的相关性.
- 评估cDDM装置在检测TDT患者的高凝血状态中的实用性,有或没有脊髓切除术.
主要方法:
- 使用cDDM装置在7分钟内测量了8μL等离子体中复杂粘度的模量.
- 血粘度测量与完整血清,PT,APTT,蛋白C,蛋白S,CD62P/CD63表达和血小板聚合相关.
- 在健康对照组和经过和没有脊髓切除术的TDT患者之间比较了粘度测量.
主要成果:
- 与健康血相比,血呈现出显著更高的 值.
- 虽然所有TDT患者都显示出高凝血标志物,但在脊髓切除术患者中,只有高血小板计数与高血粘度相关.
- 在所有TDT患者中观察到血粘度和其他可凝固参数之间的正相关性趋势.
结论:
- cDDM装置提供了一种快速,低体积的方法来评估TDT中的等离子体粘度.
- 这项技术可以作为一种方法工具,用于在TDT中早期检测高凝性.
- 通过cDDM进行早期检测可能有助于预防TEE和TDT患者的相关并发症.
相关概念视频
Equipments Used To Measure Blood Pressure
3.4K
Direct Method
This invasive approach involves cannulating a peripheral artery. During each cardiac contraction, pressure generates mechanical motion within the catheter, transmitted through rigid, fluid-filled tubing to a transducer. This transducer converts mechanical motion into electrical signals displayed as waveforms on a monitor. An automatic flushing system prevents blood backflow. Due to the potential risk of unexpected arterial blood loss, this method is primarily used in intensive...
This invasive approach involves cannulating a peripheral artery. During each cardiac contraction, pressure generates mechanical motion within the catheter, transmitted through rigid, fluid-filled tubing to a transducer. This transducer converts mechanical motion into electrical signals displayed as waveforms on a monitor. An automatic flushing system prevents blood backflow. Due to the potential risk of unexpected arterial blood loss, this method is primarily used in intensive...
3.4K
Therapeutic Drug Monitoring: Overview and Classification
642
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
642
Therapeutic Drug Monitoring: Drug Analysis Methods
342
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
342
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790


